RALEIGH, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today financial results for the fourth quarter and year ended December 31, 2010. For the quarter ended December 31, 2010, the Company reported a net loss of $4.3 million, or ($0.05) per common share, compared to a net loss of $2.6 million, or ($0.03) per common share, for the same period in 2009. Net loss for the year ended December 31, 2010 was $35.4 million, or ($0.43) per common share, compared to a net loss of $40.0 million, or ($0.60) per common share, for the same period in 2009.
